Enstilar Foam (calcipotriol and betamethasone) is a combination treatment for plaque psoriasis. It brings together a vitamin D analogue to slow down skin cell overgrowth and a corticosteroid to reduce redness and inflammation. The foam absorbs easily and is ideal for large areas of psoriasis on the body.

Calcipotriol helps normalise cell turnover while betamethasone reduces inflammation, itching and redness. This dual approach makes Enstilar effective for calming active plaques and smoothing thickened skin. The foam spreads easily and is often preferred for routine daily use.

Apply once daily to affected areas, holding the can upright and dispensing a small amount before gently massaging it into the skin. Avoid the face, genitals and flexures unless specifically advised. Allow it to dry before dressing. Treatment courses usually last up to four weeks.

Side effects may include mild burning, dryness or irritation at first. Because Enstilar contains a steroid, long-term overuse can thin the skin or cause rebound flare-ups. Rarely, excessive absorption may affect calcium levels. Report persistent irritation or worsening redness to a clinician.

Yes. The foam format spreads well through hair and is often easier to apply than creams or ointments. However, some patients still prefer a dedicated scalp product if plaques are very thick. Your clinician can advise which option suits your scalp pattern.

Many people see improvements within a few days, with clearer plaques often visible by one to two weeks. Maximum benefit usually occurs by four weeks. If psoriasis flares again, clinicians may recommend intermittent reuse or switching to maintenance therapy.

It is normally prescribed as a short course because the steroid component can cause thinning if used continuously. Some patients use Enstilar intermittently during flares while maintaining results with non-steroid treatments such as calcipotriol alone. Follow your clinician’s plan carefully.

Yes. Emollients can improve comfort and reduce dryness, but they should not be applied immediately before Enstilar. Apply Enstilar first, let it absorb for at least 15 minutes, and then apply moisturisers. This prevents dilution and ensures the active ingredients work effectively.

Enstilar contains a potent steroid and a vitamin D analogue, so it should only be used during pregnancy or breastfeeding if a clinician decides the benefits outweigh potential risks. Avoid applying on areas that may come into contact with your baby’s skin.

Yes. The betamethasone component reduces inflammation that triggers itching, while calcipotriol helps restore normal cell turnover. Many patients notice reduced itch within a few days, making the foam particularly helpful during flares that cause discomfort.

Yes. These areas often have thicker plaques that respond well to combination therapy. The foam spreads easily and softens scaling, which can improve penetration and speed up results. Consistent application is key to achieving the best outcome.

It depends on your treatment plan. Some clinicians advise spacing treatments apart because both phototherapy and calcipotriol increase UV sensitivity. Always follow guidance from your dermatology team if combining therapies.

Mild tingling may occur at first, but persistent burning or redness could mean the skin barrier is sensitive or the steroid is too strong for that area. Stopping temporarily, adjusting frequency or switching to a gentler product may help. Seek clinician advice before restarting.

No. Signs of infection such as oozing, increased pain or crusting need separate treatment first, often with antibiotics. Using Enstilar on infected plaques can worsen irritation.Get reviewed before continuing.

Enstilar foam absorbs quickly compared with ointments, reducing the chance of staining. Allow it to dry fully before getting dressed. Some patients prefer using it at night for convenience, especially when treating large areas.